RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Pfizer
P

Pfizer portfolio

Pfizer has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is CellCentric's $220M Series B+ round in May 2026, alongside Venrock Healthcare Capital Partners, Sofinnova Partners, RA Capital Management and 5 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with Fidelity, RA Capital Management and BrightEdge - American Cancer Society, most often Fidelity (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $315.45M.
Latest deal: CellCentric · May 6, 2026.

What Pfizer invests in

How Pfizer invests

StageDealsCapital in rounds
Series B+ 2 100%$315.45M
YearDealsCapital in rounds
2023 1 50%$95.45M
2026 1 50%$220M

Share is of the 2 rounds on Recent Funding that name Pfizer. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Pfizer portfolio companies

CompanyRound with PfizerTotal raisedLatest raise
CCellCentric
Health and bio
 Series B+ · $220M$340MMay 6, 2026
Series B+
AAgomab Therapeutics
Health and bio
 Series B+ · $95.45M$193.45MOct 11, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Pfizer, which is a subset of its real portfolio. API: /api/v1/investors/pfizer (get a free API key). More: the most active VC firms and new venture capital funds.